News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Walsh Jeffrey T.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Walsh Jeffrey T. (Director) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 29,532 options to buy
@ $7.12, valued at
$210.3k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| Walsh Jeffrey T. (Director) has filed a Form 3 on Tenaya Therapeutics, Inc. |
| 08/21/2019 |
4
| Walsh Jeffrey T. (Chief Strategy Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 500 shares
@ $124, valued at
$62k
Exercised 500 options to buy
@ $24.47, valued at
$12.2k
|
|
| 06/20/2019 |
4
| Walsh Jeffrey T. (Chief Strategy Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 100 shares
@ $126.12, valued at
$12.6k
Exercised 100 options to buy
@ $24.47, valued at
$2.4k
|
|
| 06/12/2019 |
4
| Walsh Jeffrey T. (Chief Strategy Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 1,200 shares
@ $125.1892, valued at
$150.2k
Sold 200 shares
@ $126.96, valued at
$25.4k
Exercised 1,400 options to buy
@ $24.47, valued at
$34.3k
|
|
| 05/14/2019 |
4
| Walsh Jeffrey T. (Chief Strategy Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 200 shares
@ $131.105, valued at
$26.2k
Sold 1,100 shares
@ $132.3755, valued at
$145.6k
Sold 200 shares
@ $133.08, valued at
$26.6k
Exercised 1,500 options to buy
@ $24.47, valued at
$36.7k
|
|
| 04/12/2019 |
4
| Walsh Jeffrey T. (Chief Strategy Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 1,100 shares
@ $156.4409, valued at
$172.1k
Sold 400 shares
@ $157.2275, valued at
$62.9k
Exercised 1,500 options to buy
@ $24.47, valued at
$36.7k
|
|
| 03/13/2019 |
4
| Walsh Jeffrey T. (Chief Strategy Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 1,500 shares
@ $139.7988, valued at
$209.7k
Exercised 1,500 options to buy
@ $24.47, valued at
$36.7k
|
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 3,000 shares
@ $125.1427, valued at
$375.4k
Exercised 3,000 options to buy
@ $24.47, valued at
$73.4k
|
|
| 01/09/2019 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 1,979 shares
@ $113.2886, valued at
$224.2k
Sold 1,033 shares
@ $114.3056, valued at
$118.1k
|
|
| 11/14/2018 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 320 shares
@ $129.1225, valued at
$41.3k
Sold 700 shares
@ $130.6129, valued at
$91.4k
Sold 480 shares
@ $131.5465, valued at
$63.1k
Exercised 1,500 options to buy
@ $24.47, valued at
$36.7k
|
|
| 10/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2018 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 501 shares
@ $149.2211, valued at
$74.8k
Sold 700 shares
@ $150.2357, valued at
$105.2k
Sold 299 shares
@ $151.5667, valued at
$45.3k
Exercised 1,500 options to buy
@ $24.47, valued at
$36.7k
|
|
| 09/04/2018 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 19,022 shares
@ $175.365, valued at
$3.3M
Sold 978 shares
@ $176.0273, valued at
$172.2k
Exercised 8,743 options to buy
@ $2.0864, valued at
$18.2k
Exercised 4,007 options to buy
@ $5.5004, valued at
$22k
Exercised 7,250 options to buy
@ $24.47, valued at
$177.4k
|
|
| 08/14/2018 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 425 shares
@ $155.4059, valued at
$66k
Sold 350 shares
@ $156.6293, valued at
$54.8k
Sold 620 shares
@ $157.8581, valued at
$97.9k
Sold 105 shares
@ $158.5667, valued at
$16.6k
Exercised 1,500 options to buy
@ $5.5004, valued at
$8.3k
|
|
| 08/06/2018 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 7,965 shares
@ $150.3137, valued at
$1.2M
Sold 3,976 shares
@ $151.5876, valued at
$602.7k
Sold 2,601 shares
@ $152.5134, valued at
$396.7k
Sold 3,358 shares
@ $153.3472, valued at
$514.9k
Sold 3,100 shares
@ $154.579, valued at
$479.2k
Sold 500 shares
@ $155.42, valued at
$77.7k
Exercised 21,500 options to buy
@ $5.5004, valued at
$118.3k
|
|
| 02/05/2018 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 11,250 shares
@ $0
Granted 45,000 options to buy
@ $205.25, valued at
$9.2M
|
|
| 01/09/2018 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 2,659 shares
@ $173.2561, valued at
$460.7k
Sold 401 shares
@ $174.1704, valued at
$69.8k
|
|
| 12/13/2017 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 1,299 shares
@ $210.2482, valued at
$273.1k
Sold 101 shares
@ $211.0594, valued at
$21.3k
Sold 1,200 shares
@ $212.7004, valued at
$255.2k
Sold 520 shares
@ $213.6462, valued at
$111.1k
Sold 380 shares
@ $214.5842, valued at
$81.5k
Sold 2,550 shares
@ $217.3318, valued at
$554.2k
Sold 950 shares
@ $218.0895, valued at
$207.2k
Sold 800 shares
@ $219.4855, valued at
$175.6k
Sold 680 shares
@ $220.5206, valued at
$150k
Sold 1,420 shares
@ $221.5169, valued at
$314.6k
Exercised 9,900 options to buy
@ $24.47, valued at
$242.3k
|
|
| 11/14/2017 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 2,100 shares
@ $148.7548, valued at
$312.4k
Sold 6,600 shares
@ $149.7363, valued at
$988.3k
Sold 1,200 shares
@ $150.1833, valued at
$180.2k
Exercised 1,493 options to buy
@ $2.0864, valued at
$3.1k
Exercised 578 options to buy
@ $5.5004, valued at
$3.2k
Exercised 7,829 options to buy
@ $24.47, valued at
$191.6k
|
|
| 11/03/2017 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 10,775 shares
@ $150.4576, valued at
$1.6M
Sold 15,462 shares
@ $151.4518, valued at
$2.3M
Sold 7,789 shares
@ $152.3022, valued at
$1.2M
Sold 974 shares
@ $153.0958, valued at
$149.1k
Exercised 35,000 options to buy
@ $5.5004, valued at
$192.5k
|
|
| 10/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2017 |
4
| Walsh Jeffrey T. (Chief Financial) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 2,500 shares
@ $100.054, valued at
$250.1k
Exercised 2,500 options to buy
@ $2.0864, valued at
$5.2k
|
|
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|